APOE and Alzheimer disease: However, we did not observe any differential expression of IGFBP3 in AD patient-derived iNs with APOE ε3/3 allele (Fig. 5b), suggesting that the upregulated IGFBP3 may be responsible for AD pathogenesis in APOE ε4-dependent sporadic AD patient iNs.